Allison Gatlin

The deal expands Supernus Pharmaceuticals' presence in the nonpsychiatric space.

Is Pfizer stock a sell after its 2024 outlook missed analysts’ expectations and weighed on other Covid vaccine makers? Is PFE stock a sell?

The group has several commonalities, including strong ratings and promising charts.

The FDA will now hold an advisory committee meeting to discuss Eli Lilly’s Alzheimer’s drug, donanemab. Is Eli Lilly stock a buy or a sell?

Regeneron Pharmaceuticals previously won 23andMe at auction. But there's a new twist in the saga.

The deal is being discussed ahead of key data from MoonLake in patients with a skin disease.

There's a long history of anti-PD-1 and anti-VEGF drugs working to slow progression, but not improve overall survival.

Regeneron stock crashed Friday after the company's Sanofi-partnered COPD treatment unexpectedly failed in a Phase 3 study.

Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025.

The company said the regulatory path forward for one of its key systems is too murky to pursue.